On December 8, 2021, staff members from the MAPS Public Benefit Corporation (MAPS PBC) conducted the second site initiation visit (SIV) for our multi-site expanded access program for MDMA-assisted therapy for patients with treatment-resistant PTSD in Berkeley, California. The site is not open for screening yet and is anticipated to open sometime in January 2022.
